427 sets of proteins participating in pathways from the WikiPathways Pathways 2014 dataset.
| Gene Set |
Description |
|
Apoptosis(Homo sapiens)
|
|
|
Regulation of Cardiac Hypertrophy by miR-208(Mus musculus)
|
|
|
Senescence and Autophagy(Homo sapiens)
|
|
|
Vitamin A and Carotenoid Metabolism(Homo sapiens)
|
|
|
IL1 and megakaryotyces in obesity(Homo sapiens)
|
|
|
Chemokine signaling pathway(Mus musculus)
|
|
|
Hypertrophy Model(Mus musculus)
|
|
|
SIDS Susceptibility Pathways(Homo sapiens)
|
|
|
Glycolysis and Gluconeogenesis(Mus musculus)
|
|
|
Polyol Pathway(Homo sapiens)
|
|
|
Glycogen Metabolism(Homo sapiens)
|
|
|
Diclofenac Metabolic Pathway(Homo sapiens)
|
|
|
Gastric cancer network 2(Homo sapiens)
|
|
|
Sphingolipid Metabolism(Homo sapiens)
|
|
|
Peptide GPCRs(Mus musculus)
|
|
|
Tamoxifen metabolism(Homo sapiens)
|
|
|
Complement Activation, Classical Pathway(Homo sapiens)
|
|
|
TNF alpha Signaling Pathway(Homo sapiens)
|
|
|
Hypothetical Network for Drug Addiction(Homo sapiens)
|
|
|
Apoptosis(Mus musculus)
|
|
|
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer(Homo sapiens)
|
|
|
ID signaling pathway(Homo sapiens)
|
|
|
Hair Follicle Development: Induction (Part 1 of 3)(Homo sapiens)
|
|
|
GPCRs, Class B Secretin-like(Mus musculus)
|
|
|
SIDS Susceptibility Pathways(Mus musculus)
|
|
|
miR-1 in cardiac development(Mus musculus)
|
|
|
Trans-sulfuration and one carbon metabolism(Homo sapiens)
|
|
|
Biogenic Amine Synthesis(Mus musculus)
|
|
|
Transcriptional activation by NRF2(Homo sapiens)
|
|
|
Vitamin D Metabolism(Homo sapiens)
|
|
|
Wnt Signaling Pathway(Homo sapiens)
|
|
|
Osteoclast Signaling(Homo sapiens)
|
|
|
G13 Signaling Pathway(Mus musculus)
|
|
|
EPO Receptor Signaling(Homo sapiens)
|
|
|
G13 Signaling Pathway(Homo sapiens)
|
|
|
FSH signaling pathway(Homo sapiens)
|
|
|
Glutathione and one carbon metabolism(Mus musculus)
|
|
|
RB in Cancer(Homo sapiens)
|
|
|
Arylhydrocarbon receptor (AhR) signaling pathway(Homo sapiens)
|
|
|
Felbamate Metabolism(Homo sapiens)
|
|
|
One carbon metabolism and related pathways(Mus musculus)
|
|
|
Electron Transport Chain(Homo sapiens)
|
|
|
TWEAK Signaling Pathway(Homo sapiens)
|
|
|
BDNF signaling pathway(Homo sapiens)
|
|
|
AMPK Signaling(Homo sapiens)
|
|
|
Dopamine metabolism(Homo sapiens)
|
|
|
ESC Pluripotency Pathways(Mus musculus)
|
|
|
FAS pathway and Stress induction of HSP regulation(Homo sapiens)
|
|
|
Allograft Rejection(Homo sapiens)
|
|
|
Integrin-mediated Cell Adhesion(Homo sapiens)
|
|
|
Sulfation Biotransformation Reaction(Homo sapiens)
|
|
|
Estrogen metabolism(Homo sapiens)
|
|
|
Fluoropyrimidine Activity(Homo sapiens)
|
|
|
Triacylglyceride Synthesis(Mus musculus)
|
|
|
Prostaglandin Synthesis and Regulation(Homo sapiens)
|
|
|
Serotonin and anxiety(Mus musculus)
|
|
|
G Protein Signaling Pathways(Homo sapiens)
|
|
|
Histone modifications(Mus musculus)
|
|
|
Mismatch repair(Mus musculus)
|
|
|
Ptf1a related regulatory pathway(Mus musculus)
|
|
|
miRNAs involved in DNA damage response(Homo sapiens)
|
|
|
RNA interference(Homo sapiens)
|
|
|
Id Signaling Pathway(Mus musculus)
|
|
|
Cytoplasmic Ribosomal Proteins(Mus musculus)
|
|
|
IL-5 Signaling Pathway(Homo sapiens)
|
|
|
Semaphorin interactions(Homo sapiens)
|
|
|
IL-6 signaling Pathway(Mus musculus)
|
|
|
G1 to S cell cycle control(Mus musculus)
|
|
|
Pentose Phosphate Pathway(Mus musculus)
|
|
|
Apoptosis-related network due to altered Notch3 in ovarian cancer(Homo sapiens)
|
|
|
Spinal Cord Injury(Homo sapiens)
|
|
|
Leptin signaling pathway(Homo sapiens)
|
|
|
Signaling of Hepatocyte Growth Factor Receptor(Mus musculus)
|
|
|
Cell Cycle(Homo sapiens)
|
|
|
Diurnally Regulated Genes with Circadian Orthologs(Homo sapiens)
|
|
|
miRNA Biogenesis(Homo sapiens)
|
|
|
Colchicine Metabolic Pathway(Homo sapiens)
|
|
|
Folic Acid Network(Mus musculus)
|
|
|
Influenza A virus infection(Homo sapiens)
|
|
|
miRNA Regulation of DNA Damage Response(Homo sapiens)
|
|
|
Synthesis and Degradation of Ketone Bodies(Mus musculus)
|
|
|
IL-9 Signaling Pathway(Homo sapiens)
|
|
|
Structural Pathway of Interleukin 1 (IL-1)(Homo sapiens)
|
|
|
ErbB Signaling Pathway(Homo sapiens)
|
|
|
Gene regulatory network modelling somitogenesis (Homo sapiens)
|
|
|
Methylation(Mus musculus)
|
|
|
IL-3 Signaling Pathway(Homo sapiens)
|
|
|
Serotonin Receptor 4/6/7 and NR3C Signaling(Homo sapiens)
|
|
|
Non-odorant GPCRs(Mus musculus)
|
|
|
Proteasome Degradation(Homo sapiens)
|
|
|
miR-targeted genes in lymphocytes - TarBase(Homo sapiens)
|
|
|
Corticotropin-releasing hormone(Homo sapiens)
|
|
|
B Cell Receptor Signaling Pathway(Homo sapiens)
|
|
|
Statin Pathway(Homo sapiens)
|
|
|
Amino acid conjugation of benzoic acid(Mus musculus)
|
|
|
EBV LMP1 signaling(Mus musculus)
|
|
|
Hedgehog Signaling Pathway(Mus musculus)
|
|
|
p38 MAPK Signaling Pathway(Homo sapiens)
|
|
|
Gastric acid production(Homo sapiens)
|
|
|
Prostaglandin Synthesis and Regulation(Mus musculus)
|
|
|
TGF Beta Signaling Pathway(Homo sapiens)
|
|
|
Proteasome Degradation(Mus musculus)
|
|
|
MAPK signaling pathway(Mus musculus)
|
|
|
Spinal Cord Injury(Mus musculus)
|
|
|
Heart Development(Mus musculus)
|
|
|
Nucleotide Metabolism(Homo sapiens)
|
|
|
Endochondral Ossification(Homo sapiens)
|
|
|
Selenium metabolism/Selenoproteins(Mus musculus)
|
|
|
Selenium Metabolism and Selenoproteins(Homo sapiens)
|
|
|
Interferon type I signaling pathways(Homo sapiens)
|
|
|
Focal Adhesion(Homo sapiens)
|
|
|
Integrated Breast Cancer Pathway(Homo sapiens)
|
|
|
Leptin Insulin Overlap(Mus musculus)
|
|
|
Trans-sulfuration pathway(Homo sapiens)
|
|
|
IL-7 Signaling Pathway(Mus musculus)
|
|
|
EPO Receptor Signaling(Mus musculus)
|
|
|
Selenium Micronutrient Network(Homo sapiens)
|
|
|
Irinotecan Pathway(Homo sapiens)
|
|
|
Glycogen Metabolism(Mus musculus)
|
|
|
Fatty Acid Biosynthesis(Homo sapiens)
|
|
|
Mitochondrial Gene Expression(Mus musculus)
|
|
|
Tryptophan metabolism(Homo sapiens)
|
|
|
Adipogenesis genes(Mus musculus)
|
|
|
Fatty Acid Omega Oxidation(Mus musculus)
|
|
|
Signal Transduction of S1P Receptor(Homo sapiens)
|
|
|
Regulation of toll-like receptor signaling pathway(Homo sapiens)
|
|
|
Oxidative Stress(Mus musculus)
|
|
|
Alpha 6 Beta 4 signaling pathway(Homo sapiens)
|
|
|
Polyol pathway(Mus musculus)
|
|
|
Biogenic Amine Synthesis(Homo sapiens)
|
|
|
Mitochondrial LC-Fatty Acid Beta-Oxidation(Mus musculus)
|
|
|
Parkin-Ubiquitin Proteasomal System pathway(Homo sapiens)
|
|
|
miR-targeted genes in adipocytes - TarBase(Homo sapiens)
|
|
|
IL17 signaling pathway(Homo sapiens)
|
|
|
Ovarian Infertility Genes(Mus musculus)
|
|
|
Alzheimers Disease(Homo sapiens)
|
|
|
mir34a and TGIF2 in osteoclastogenesis(Homo sapiens)
|
|
|
miR-targeted genes in muscle cell - TarBase(Homo sapiens)
|
|
|
Calcium Regulation in the Cardiac Cell(Mus musculus)
|
|
|
Calcium Regulation in the Cardiac Cell(Homo sapiens)
|
|
|
ACE Inhibitor Pathway(Mus musculus)
|
|
|
Synthesis and Degradation of Ketone Bodies(Homo sapiens)
|
|
|
Heme Biosynthesis(Homo sapiens)
|
|
|
Small Ligand GPCRs(Mus musculus)
|
|
|
SREBF and miR33 in cholesterol and lipid homeostasis(Homo sapiens)
|
|
|
Pentose Phosphate Pathway(Homo sapiens)
|
|
|
Secretion of Hydrochloric Acid in Parietal Cells(Homo sapiens)
|
|
|
Translation Factors(Homo sapiens)
|
|
|
Metastatic brain tumor(Homo sapiens)
|
|
|
One Carbon Metabolism(Homo sapiens)
|
|
|
miRNA regulation of DNA Damage Response(Mus musculus)
|
|
|
Acetylcholine Synthesis(Homo sapiens)
|
|
|
Signaling Pathways in Glioblastoma(Homo sapiens)
|
|
|
Deregulation of Rab and Rab Effector Genes in Bladder Cancer(Homo sapiens)
|
|
|
Kit Receptor Signaling Pathway(Mus musculus)
|
|
|
Effects of Nitric Oxide(Homo sapiens)
|
|
|
Complement Activation, Classical Pathway(Mus musculus)
|
|
|
Neurotransmitter Release Cycle(Homo sapiens)
|
|
|
Butyrate-induced histone acetylation(Homo sapiens)
|
|
|
Acetylcholine Synthesis(Mus musculus)
|
|
|
Metapathway biotransformation(Homo sapiens)
|
|
|
SREBP signalling(Homo sapiens)
|
|
|
Type II diabetes mellitus(Homo sapiens)
|
|
|
Iron uptake and transport(Homo sapiens)
|
|
|
Cytokines and Inflammatory Response (BioCarta)(Mus musculus)
|
|
|
Endochondral Ossification(Mus musculus)
|
|
|
Osteoblast Signaling(Homo sapiens)
|
|
|
GPCRs, Class B Secretin-like(Homo sapiens)
|
|
|
Glucocorticoid & Mineralcorticoid Metabolism(Mus musculus)
|
|
|
PPAR signaling pathway(Mus musculus)
|
|
|
Physiological and Pathological Hypertrophy of the Heart(Homo sapiens)
|
|
|
Catalytic cycle of mammalian FMOs(Homo sapiens)
|
|
|
Cardiac Hypertrophic Response(Homo sapiens)
|
|
|
Estrogen signalling(Mus musculus)
|
|
|
Glutathione metabolism(Homo sapiens)
|
|
|
Cholesterol Biosynthesis(Mus musculus)
|
|
|
Matrix Metalloproteinases(Homo sapiens)
|
|
|
mRNA processing(Mus musculus)
|
|
|
Cytokines and Inflammatory Response(Homo sapiens)
|
|
|
Diurnally Regulated Genes with Circadian Orthologs(Mus musculus)
|
|
|
Primary Focal Segmental Glomerulosclerosis FSGS(Homo sapiens)
|
|
|
Delta-Notch Signaling Pathway(Mus musculus)
|
|
|
Nanoparticle-mediated activation of receptor signaling(Homo sapiens)
|
|
|
Glucuronidation(Homo sapiens)
|
|
|
IL-2 Signaling Pathway(Homo sapiens)
|
|
|
Urea cycle and metabolism of amino groups(Homo sapiens)
|
|
|
Apoptosis Modulation and Signaling(Homo sapiens)
|
|
|
Amino acid conjugation of benzoic acid(Homo sapiens)
|
|
|
Fatty Acid Beta Oxidation(Mus musculus)
|
|
|
Splicing factor NOVA regulated synpatic proteins(Mus musculus)
|
|
|
Alanine and aspartate metabolism(Mus musculus)
|
|
|
Parkinsons Disease Pathway(Homo sapiens)
|
|
|
Heart Development(Homo sapiens)
|
|
|
Striated Muscle Contraction(Mus musculus)
|
|
|
TP53 Network(Homo sapiens)
|
|
|
Globo Sphingolipid Metabolism(Homo sapiens)
|
|
|
IL-3 Signaling Pathway(Mus musculus)
|
|
|
Cytoplasmic Ribosomal Proteins(Homo sapiens)
|
|
|
Peroxisomal beta-oxidation of tetracosanoyl-CoA(Homo sapiens)
|
|
|
Cardiac Progenitor Differentiation(Homo sapiens)
|
|
|
G Protein Signaling Pathways(Mus musculus)
|
|
|
SREBF and miR33 in cholesterol and lipid homeostasis(Mus musculus)
|
|
|
PDGF Pathway(Homo sapiens)
|
|
|
Signaling of Hepatocyte Growth Factor Receptor(Homo sapiens)
|
|
|
Osteoblast(Mus musculus)
|
|
|
TarBasePathway(Homo sapiens)
|
|
|
Arachidonate Epoxygenase Epoxide Hydrolase(Mus musculus)
|
|
|
Osteopontin Signaling(Homo sapiens)
|
|
|
Irinotecan Pathway(Mus musculus)
|
|
|
IL-1 Signaling Pathway(Mus musculus)
|
|
|
Glycine Metabolism(Homo sapiens)
|
|
|
Fatty Acid Omega Oxidation(Homo sapiens)
|
|
|
Insulin Signaling(Homo sapiens)
|
|
|
Mitochondrial LC-Fatty Acid Beta-Oxidation(Homo sapiens)
|
|
|
Oxidative Stress(Homo sapiens)
|
|
|
Insulin Signaling(Mus musculus)
|
|
|
Cori Cycle(Homo sapiens)
|
|
|
Striated Muscle Contraction(Homo sapiens)
|
|
|
Nicotine Activity on Chromaffin Cells(Homo sapiens)
|
|
|
Oxidative phosphorylation(Mus musculus)
|
|
|
Mitochondrial Gene Expression(Homo sapiens)
|
|
|
Oxidative phosphorylation(Homo sapiens)
|
|
|
Serotonin and anxiety-related events(Mus musculus)
|
|
|
Wnt Signaling Pathway and Pluripotency(Homo sapiens)
|
|
|
Interleukin-11 Signaling Pathway(Homo sapiens)
|
|
|
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling(Homo sapiens)
|
|
|
Hypothetical Network for Drug Addiction(Mus musculus)
|
|
|
Odorant GPCRs(Mus musculus)
|
|
|
DNA Replication(Mus musculus)
|
|
|
Adipogenesis(Homo sapiens)
|
|
|
Hedgehog Signaling Pathway(Homo sapiens)
|
|
|
Retinol metabolism(Mus musculus)
|
|
|
Toll-like receptor signaling pathway(Homo sapiens)
|
|
|
GPCRs, Class A Rhodopsin-like(Homo sapiens)
|
|
|
Regulation of Actin Cytoskeleton(Mus musculus)
|
|
|
Quercetin and Nf-kB/ AP-1 induced cell apoptosis(Homo sapiens)
|
|
|
Wnt Signaling Pathway Netpath(Homo sapiens)
|
|
|
GPCRs, Other(Homo sapiens)
|
|
|
Regulation of Actin Cytoskeleton(Homo sapiens)
|
|
|
Leptin and adiponectin(Mus musculus)
|
|
|
Estrogen metabolism(Mus musculus)
|
|
|
Pathogenic Escherichia coli infection(Homo sapiens)
|
|
|
Nuclear Receptors(Mus musculus)
|
|
|
PodNet: protein-protein interactions in the podocyte(Mus musculus)
|
|
|
DNA Damage Response(Homo sapiens)
|
|
|
TCA Cycle(Mus musculus)
|
|
|
Heme Biosynthesis(Mus musculus)
|
|
|
RalA downstream regulated genes(Homo sapiens)
|
|
|
Small Ligand GPCRs(Homo sapiens)
|
|
|
Apoptosis Modulation by HSP70(Homo sapiens)
|
|
|
Fatty acid oxidation(Mus musculus)
|
|
|
miR-targeted genes in leukocytes - TarBase(Homo sapiens)
|
|
|
Arrhythmogenic Right Ventricular Cardiomyopathy(Homo sapiens)
|
|
|
Glycolysis and Gluconeogenesis(Homo sapiens)
|
|
|
Selenium Micronutrient Network(Mus musculus)
|
|
|
miR-targeted genes in squamous cell - TarBase(Homo sapiens)
|
|
|
IL-5 Signaling Pathway(Mus musculus)
|
|
|
Dopminergic Neurogenesis(Homo sapiens)
|
|
|
Blood Clotting Cascade(Mus musculus)
|
|
|
Gastric cancer network 1(Homo sapiens)
|
|
|
One Carbon Metabolism(Mus musculus)
|
|
|
Nicotine Metabolism(Homo sapiens)
|
|
|
IL-4 Signaling Pathway(Homo sapiens)
|
|
|
NLR Proteins(Homo sapiens)
|
|
|
Non-homologous end joining(Mus musculus)
|
|
|
Matrix Metalloproteinases(Mus musculus)
|
|
|
Iron metabolism in placenta(Homo sapiens)
|
|
|
Metapathway biotransformation(Mus musculus)
|
|
|
Integrin-mediated Cell Adhesion(Mus musculus)
|
|
|
Nuclear Receptors(Homo sapiens)
|
|
|
Fatty Acid Beta Oxidation(Homo sapiens)
|
|
|
Nicotine Activity on Dopaminergic Neurons(Homo sapiens)
|
|
|
MAPK Cascade(Homo sapiens)
|
|
|
Glutathione metabolism(Mus musculus)
|
|
|
mRNA Processing(Homo sapiens)
|
|
|
Nucleotide GPCRs(Homo sapiens)
|
|
|
Type III interferon signaling(Homo sapiens)
|
|
|
FAS pathway and Stress induction of HSP regulation(Mus musculus)
|
|
|
Homologous recombination(Mus musculus)
|
|
|
Mismatch repair(Homo sapiens)
|
|
|
MicroRNAs in Cardiomyocyte Hypertrophy(Mus musculus)
|
|
|
Complement and Coagulation Cascades(Homo sapiens)
|
|
|
ATM Signaling Pathway(Homo sapiens)
|
|
|
Oncostatin M Signaling Pathway(Homo sapiens)
|
|
|
Alanine and aspartate metabolism(Homo sapiens)
|
|
|
Cholesterol Biosynthesis(Homo sapiens)
|
|
|
Angiogenesis(Homo sapiens)
|
|
|
DNA Replication(Homo sapiens)
|
|
|
Eukaryotic Transcription Initiation(Homo sapiens)
|
|
|
MAPK Signaling Pathway(Homo sapiens)
|
|
|
Translation Factors(Mus musculus)
|
|
|
Sulindac Metabolic Pathway(Homo sapiens)
|
|
|
Myometrial Relaxation and Contraction Pathways(Homo sapiens)
|
|
|
Membrane Trafficking(Homo sapiens)
|
|
|
Macrophage markers(Mus musculus)
|
|
|
Aflatoxin B1 metabolism(Mus musculus)
|
|
|
Myometrial Relaxation and Contraction Pathways(Mus musculus)
|
|
|
Eukaryotic Transcription Initiation(Mus musculus)
|
|
|
RANKL/RANK Signaling Pathway(Homo sapiens)
|
|
|
Extracellular vesicle-mediated signaling in recipient cells(Homo sapiens)
|
|
|
Folate-Alcohol and Cancer Pathway(Homo sapiens)
|
|
|
Non-homologous end joining(Homo sapiens)
|
|
|
Ovarian Infertility Genes(Homo sapiens)
|
|
|
Iron Homeostasis(Mus musculus)
|
|
|
Type II interferon signaling (IFNG)(Homo sapiens)
|
|
|
Peptide GPCRs(Homo sapiens)
|
|
|
Eicosanoid Synthesis(Homo sapiens)
|
|
|
Estrogen signaling pathway(Homo sapiens)
|
|
|
IL-7 Signaling Pathway(Homo sapiens)
|
|
|
IL-6 signaling pathway(Homo sapiens)
|
|
|
Aryl Hydrocarbon Receptor(Homo sapiens)
|
|
|
Differentiation Pathway(Homo sapiens)
|
|
|
Glucocorticoid & Mineralcorticoid Metabolism(Homo sapiens)
|
|
|
TSLP Signaling Pathway(Homo sapiens)
|
|
|
Thyroxine (Thyroid Hormone) Production(Homo sapiens)
|
|
|
Phase I biontransformations, non P450(Mus musculus)
|
|
|
Oxidation by Cytochrome P450(Homo sapiens)
|
|
|
Amyotrophic lateral sclerosis (ALS)(Homo sapiens)
|
|
|
Benzo(a)pyrene metabolism(Homo sapiens)
|
|
|
TGF Beta Signaling Pathway(Mus musculus)
|
|
|
Neurotransmitter Clearance In The Synaptic Cleft(Homo sapiens)
|
|
|
TFs Regulate miRNAs related to cardiac hypertrophy(Homo sapiens)
|
|
|
Electron Transport Chain(Mus musculus)
|
|
|
Alzheimers Disease(Mus musculus)
|
|
|
TCA Cycle(Homo sapiens)
|
|
|
Wnt Signaling Pathway NetPath(Mus musculus)
|
|
|
Wnt Signaling Pathway and Pluripotency(Mus musculus)
|
|
|
EGFR1 Signaling Pathway(Mus musculus)
|
|
|
PCSK9-mediated LDLR degradation(Homo sapiens)
|
|
|
Monoamine GPCRs(Homo sapiens)
|
|
|
Integrated Cancer pathway(Homo sapiens)
|
|
|
Arylamine metabolism(Homo sapiens)
|
|
|
Notch Signaling Pathway(Homo sapiens)
|
|
|
Ganglio Sphingolipid Metabolism(Homo sapiens)
|
|
|
Monoamine Transport(Homo sapiens)
|
|
|
Hematopoietic Stem Cell Differentiation(Homo sapiens)
|
|
|
Glucuronidation(Mus musculus)
|
|
|
Glycerophospholipid Biosynthetic Pathway(Homo sapiens)
|
|
|
ACE Inhibitor Pathway(Homo sapiens)
|
|
|
ErbB signaling pathway(Mus musculus)
|
|
|
miRs in Muscle Cell Differentiation(Homo sapiens)
|
|
|
Kennedy pathway(Mus musculus)
|
|
|
BMP Signalling and Regulation(Homo sapiens)
|
|
|
Amino Acid metabolism(Mus musculus)
|
|
|
GPCRs, Class C Metabotropic glutamate, pheromone(Mus musculus)
|
|
|
Nuclear receptors in lipid metabolism and toxicity(Mus musculus)
|
|
|
Toll Like Receptor signaling(Mus musculus)
|
|
|
Osteoclast(Mus musculus)
|
|
|
NLR Proteins(Mus musculus)
|
|
|
miR-targeted genes in epithelium - TarBase(Homo sapiens)
|
|
|
TOR Signaling(Homo sapiens)
|
|
|
Arachidonate Epoxygenase / Epoxide Hydrolase(Homo sapiens)
|
|
|
Statin Pathway(Mus musculus)
|
|
|
Drug Induction of Bile Acid Pathway(Homo sapiens)
|
|
|
TNF-alpha NF-kB Signaling Pathway(Mus musculus)
|
|
|
Serotonin Transporter Activity(Homo sapiens)
|
|
|
Lidocaine metabolism(Homo sapiens)
|
|
|
Keap1-Nrf2(Mus musculus)
|
|
|
Signal Transduction of S1P Receptor(Mus musculus)
|
|
|
Integrated Pancreatic Cancer Pathway(Homo sapiens)
|
|
|
p38 MAPK Signaling Pathway(Mus musculus)
|
|
|
Histone Modifications(Homo sapiens)
|
|
|
Apoptosis Modulation by HSP70(Mus musculus)
|
|
|
Inflammatory Response Pathway(Mus musculus)
|
|
|
Codeine and Morphine Metabolism(Homo sapiens)
|
|
|
Serotonin Receptor 2 and STAT3 Signaling(Homo sapiens)
|
|
|
Triacylglyceride Synthesis(Homo sapiens)
|
|
|
DNA Damage Response (only ATM dependent)(Homo sapiens)
|
|
|
Notch Signaling Pathway(Mus musculus)
|
|
|
Dopminergic Neurogenesis(Mus musculus)
|
|
|
Blood Clotting Cascade(Homo sapiens)
|
|
|
XPodNet - protein-protein interactions in the podocyte expanded by STRING(Mus musculus)
|
|
|
TCR Signaling Pathway(Homo sapiens)
|
|
|
Neural retinal development(Mus musculus)
|
|
|
Nuclear Receptors in Lipid Metabolism and Toxicity(Homo sapiens)
|
|
|
Methylation Pathways(Homo sapiens)
|
|
|
Vitamin B12 Metabolism(Homo sapiens)
|
|
|
Exercise-induced Circadian Regulation(Mus musculus)
|
|
|
Phase I biotransformations, non P450(Homo sapiens)
|
|
|
Folate Metabolism(Homo sapiens)
|
|
|
GPCRs, Other(Mus musculus)
|
|
|
PluriNetWork(Mus musculus)
|
|
|
Kit receptor signaling pathway(Homo sapiens)
|
|
|
GPCRs, Class A Rhodopsin-like(Mus musculus)
|
|
|
G1 to S cell cycle control(Homo sapiens)
|
|
|
EGF/EGFR Signaling Pathway(Homo sapiens)
|
|
|
Complement and Coagulation Cascades(Mus musculus)
|
|
|
Type II interferon signaling (IFNG)(Mus musculus)
|
|
|
Neural Crest Differentiation(Homo sapiens)
|
|
|
Focal Adhesion(Mus musculus)
|
|
|
GPCRs, Class C Metabotropic glutamate, pheromone(Homo sapiens)
|
|
|
EBV LMP1 signaling(Homo sapiens)
|
|
|
Tryptophan metabolism(Mus musculus)
|
|
|
One carbon donor(Homo sapiens)
|
|
|
MicroRNAs in cardiomyocyte hypertrophy(Homo sapiens)
|
|
|
Steroid Biosynthesis(Mus musculus)
|
|
|
Pilocytic astrocytoma(Homo sapiens)
|
|
|
Synaptic Vesicle Pathway(Homo sapiens)
|
|
|
Hypertrophy Model(Homo sapiens)
|
|
|
Aflatoxin B1 metabolism(Homo sapiens)
|
|
|
AGE/RAGE pathway(Homo sapiens)
|
|
|
Regulation of Microtubule Cytoskeleton(Homo sapiens)
|
|
|
Alpha6-Beta4 Integrin Signaling Pathway(Mus musculus)
|
|
|
Wnt Signaling Pathway(Mus musculus)
|
|
|
Steroid Biosynthesis(Homo sapiens)
|
|
|
Purine metabolism(Mus musculus)
|
|
|
Orphan GPCRs(Mus musculus)
|
|
|
TSH signaling pathway(Homo sapiens)
|
|
|
Monoamine GPCRs(Mus musculus)
|
|
|
Eicosanoid Synthesis(Mus musculus)
|
|
|
Nucleotide Metabolism(Mus musculus)
|
|
|
Endothelin Pathways(Homo sapiens)
|
|
|
T-Cell Receptor and Co-stimulatory Signaling(Homo sapiens)
|
|
|
SRF and miRs in Smooth Muscle Differentiation and Proliferation(Homo sapiens)
|
|
|
Homologous recombination(Homo sapiens)
|
|
|
Oxidative Damage(Mus musculus)
|
|
|
Oxidation by Cytochrome P450(Mus musculus)
|
|
|
NOD pathway(Homo sapiens)
|
|
|
Androgen receptor signaling pathway(Homo sapiens)
|
|
|
NAD Biosynthesis II (from tryptophan)(Homo sapiens)
|
|
|
Nucleotide GPCRs(Mus musculus)
|
|
|
Glial Cell Differentiation(Homo sapiens)
|
|
|
MAPK Cascade(Mus musculus)
|
|
|
IL-1 signaling pathway(Homo sapiens)
|
|
|
Inflammatory Response Pathway(Homo sapiens)
|
|
|
Fatty Acid Biosynthesis(Mus musculus)
|
|
|
IL-9 Signaling Pathway(Mus musculus)
|
|
